Law office of Brodsky & Smith, LLC announces that it is investigating DaVita, Inc (“DaVita” or the “Company”) (NYSE: DVA). The investigation concerns the effect that two ongoing federal investigations into overbilling Medicare will have on the Company. An analyst has noted that recent ruling could pose a significant risk to the Company based upon damages available under the False Claims Act. Shares of DaVita stock have suffered significant losses as DaVita stock traded at $74.75 as recently as September 7, 2011 and traded at $89.36 on July 7, 2011.

If you are a current holder of DaVita stock and wish to discuss the investigation, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, visiting http://brodsky-smith.com/337-dva-davita-inc.html, or by calling toll free 877-LEGAL-90.

DaVita (NYSE:DVA)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more DaVita Charts.
DaVita (NYSE:DVA)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more DaVita Charts.